These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3290702)

  • 21. A further British case of growth hormone induced Creutzfeldt-Jakob disease.
    Ellis CJ; Katifi H; Weller RO
    J Neurol Neurosurg Psychiatry; 1992 Dec; 55(12):1200-2. PubMed ID: 1479400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Degenerative neurologic disease in patients formerly treated with human growth hormone. Report of the Committee on Growth Hormone Use of the Lawson Wilkins Pediatric Endocrine Society, May 1985.
    J Pediatr; 1985 Jul; 107(1):10-2. PubMed ID: 3891943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Creutzfeldt-Jakob disease with reference to the safety of pituitary growth hormone.
    Bannister BA; McCormick A
    J Infect; 1987 Jan; 14(1):7-12. PubMed ID: 3546511
    [No Abstract]   [Full Text] [Related]  

  • 24. [The risk in using growth hormone obtained from human pituitary glands].
    Romer T
    Endokrynol Pol; 1986; 37(4):189-91. PubMed ID: 3549269
    [No Abstract]   [Full Text] [Related]  

  • 25. Human growth hormone therapy and Creutzfeldt-Jakob disease: a drama in three acts.
    Brown P
    Pediatrics; 1988 Jan; 81(1):85-92. PubMed ID: 3275936
    [No Abstract]   [Full Text] [Related]  

  • 26. French officials panic over rare brain disease outbreak.
    Aldhous P
    Science; 1992 Dec; 258(5088):1571-2. PubMed ID: 1455242
    [No Abstract]   [Full Text] [Related]  

  • 27. Human growth hormone treatment and Creutzfeldt-Jakob disease.
    Sartorio A; Arosio M; Faglia G; Resentini M; Morabito F
    J Endocrinol Invest; 1986 Oct; 9(5):439. PubMed ID: 3540083
    [No Abstract]   [Full Text] [Related]  

  • 28. The national hormone and pituitary program (NHPP) historical perspective.
    Raiti S
    Acta Endocrinol Suppl (Copenh); 1986; 279():66-70. PubMed ID: 3535341
    [No Abstract]   [Full Text] [Related]  

  • 29. Iatrogenic Creutzfeldt-Jakob disease following human growth hormone therapy: case report.
    Caboclo LO; Huang N; Lepski GA; Livramento JA; Buchpiguel CA; Porto CS; Nitrini R
    Arq Neuropsiquiatr; 2002 Jun; 60(2-B):458-61. PubMed ID: 12131950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Creutzfeldt-Jakob disease: further similarities with kuru.
    Adams H; Beck E; Shenkin AM
    J Neurol Neurosurg Psychiatry; 1974 Feb; 37(2):195-200. PubMed ID: 4362244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The prismatic case of Creutzfeldt-Jakob disease associated with pituitary growth hormone treatment.
    Hintz RL
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2298-301. PubMed ID: 7629222
    [No Abstract]   [Full Text] [Related]  

  • 32. Brain and CSF proteins in Creutzfeldt-Jakob disease.
    Olsson JE
    Eur Neurol; 1980; 19(2):85-90. PubMed ID: 6156071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Eternal vigilance--mortality in children with growth hormone deficiency.
    Hintz RL
    J Clin Endocrinol Metab; 1996 May; 81(5):1691-2. PubMed ID: 8626816
    [No Abstract]   [Full Text] [Related]  

  • 34. Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States.
    Fradkin JE; Schonberger LB; Mills JL; Gunn WJ; Piper JM; Wysowski DK; Thomson R; Durako S; Brown P
    JAMA; 1991 Feb; 265(7):880-4. PubMed ID: 1992185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hypophyseal growth hormone and Creutzfeldt-Jakob disease in The Netherlands. Ad hoc Commission Creutzfeldt-Jakob-disease of the Dutch Growth Foundation].
    Rikken B; Massa GG; Wit JM; van den Brande JL
    Ned Tijdschr Geneeskd; 1996 Jun; 140(22):1163-5. PubMed ID: 8692348
    [No Abstract]   [Full Text] [Related]  

  • 36. Pre-mortem diagnosis of Creutzfeldt-Jakob disease by detection of abnormal cerebrospinal fluid proteins.
    Blisard KS; Davis LE; Harrington MG; Lovell JK; Kornfeld M; Berger ML
    J Neurol Sci; 1990 Oct; 99(1):75-81. PubMed ID: 2250174
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sporadic Creutzfeldt-Jakob disease with MM1-type prion protein and plaques.
    Ishida C; Kakishima A; Okino S; Furukawa Y; Kano M; Oda Y; Nakanishi I; Makifuchi T; Kitamoto T; Yamada M
    Neurology; 2003 Feb; 60(3):514-7. PubMed ID: 12578942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Creutzfeldt-Jakob disease transmitted by a cadaveric dura mater graft.
    Yamada S; Aiba T; Endo Y; Hara M; Kitamoto T; Tateishi J
    Neurosurgery; 1994 Apr; 34(4):740-3; discussion 743-4. PubMed ID: 8008177
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Creutzfeldt-Jakob disease after administration of human growth hormone.
    Powell-Jackson J; Weller RO; Kennedy P; Preece MA; Whitcombe EM; Newsom-Davis J
    Lancet; 1985 Aug; 2(8449):244-6. PubMed ID: 2862420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropathological findings in new variant CJD and experimental transmission of BSE.
    Ironside JW
    FEMS Immunol Med Microbiol; 1998 Jun; 21(2):91-5. PubMed ID: 9684997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.